Hexyme

Active hexose correlated compound (AHCC)

AHCC, 500 mg tablets
Other ingredients:maltodextrin and magnesium stearate
Indication: Modulating immune system, managing HPV infection, Reduction of side effects caused by chemotherapy
Dosing: 2 tablet per day (1 g)
Contraindication: Allergic to any ingredient in Hexyme, auto-immune disease such as multiple sclerosis (MS), systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA), eosinophilia

Side effects: Hexyme is likely safe and well-tolerated when consumed in determined dosage, but like all products, Hexyme can cause side effects that include:

Gastrointestinal complications (such as nausea, diarrhea or bloating)
Allergic reactions
Headache
Fatigue
Foot cramps

Pregnancy & Lactation:If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this product.

What is Hexyme?

Hexyme® is a mixture of compounds generated by the liquid culture of shiitake mushroom mycelium cells. The main polysaccharide and active component of Hexyme® is "Acetylated a-Glucans" which is responsible for its immunostimulatory activity within the cell.

How does HEXYME work?

• Hexyme suppresses interferon-ß levels that lead to modulation of the cytotoxic cell immunity. • Hexyme maintains the natural killer cell count. • Hexyme reduces the severity of neutropenia induced by breast cancer chemotherapy.

Literature review

Hexyme® treatment modulates the host immune response to effectively clear of HR-HPV infections

Treatment with Hexyme 1g responded within 7 months

Taking 3g Hexyme achieved faster response

References

1. From Bench to Bedside: Evaluation of AHCC Supplementation to Modulate the Host Immunity to Clear High-Risk Human Papillomavirus Infections 2. AHCC® Supplementation to Support Immune Function to Clear Persistent Human Papillomavirus Infections 3. Interferon-beta treatment increases human papillomavirus early gene transcription and viral plasmid genome replication by activating interferon regulatory factor (IRF)-1 4. Effects of active hexose correlated compound on frequency of CD4 and CD8 T cells producing interferon- and/or tumor necrosis factor in healthy adults